Hehlmann R, Lauseker M, Saussele S. et al. Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase. ASH 59th Annual Meeting & Exhibition, abstract 897.
CD47-remmer Hu5F9-G4 plus rituximab bij non-hodgkinlymfoom
jan 2019 | Lymfoom